Edges in Network
| Network | GSE16446_top500tf - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | BCL3 |
| Upstream (Parents) |
|---|
| (<<) RORC → BCL3 |
| (<<) IRF1 → BCL3 |
| (<<) CREB3L1 → BCL3 |
| (<<) THRB → BCL3 |
| (<<) TFAP2C → BCL3 |
| (<<) IRF7 → BCL3 |
| (<<) NFYA → BCL3 |
| (<<) RARA → BCL3 |
| (<<) FUBP1 → BCL3 |
| (<<) GATAD2B → BCL3 |
| (<<) ZNF232 → BCL3 |
| (<<) DBP → BCL3 |
| (<<) GCFC1 → BCL3 |
| (<<) RELB → BCL3 |
| (<<) SUPT6H → BCL3 |
| (<<) SPI1 → BCL3 |
| (<<) TBX22 → BCL3 |
| (<<) BATF → BCL3 |
| Downstream (Children) |
|---|
| BCL3 → SIX1 (>>) |
| BCL3 → FOXI1 (>>) |
| BCL3 → MECOM (>>) |
| BCL3 → NR3C2 (>>) |
| BCL3 → NPAS2 (>>) |
| BCL3 → SREBF1 (>>) |
| BCL3 → MXD1 (>>) |
| BCL3 → HMGA2 (>>) |
| BCL3 → CTNNB1 (>>) |
| BCL3 → VDR (>>) |
| BCL3 → FOXO6 (>>) |
| BCL3 → FOXP4 (>>) |
| BCL3 → SOX18 (>>) |
| BCL3 → RBCK1 (>>) |
| BCL3 → ZNF174 (>>) |
| BCL3 → SOLH (>>) |
| BCL3 → YEATS4 (>>) |
| BCL3 → NFIC (>>) |
